London biotech completes $2.5M micro IPO; AGTC touts early gene therapy data — but investors keep their distance
These days, you make do with what you can get from the public biotech markets.
For its first flight across the pond, London-based OKYO Pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
